Literature DB >> 2055654

Chronic bacterial prostatitis: therapeutic experience with ciprofloxacin.

W Weidner1, H G Schiefer.   

Abstract

Ciprofloxacin was used for the treatment of refractory chronic bacterial prostatis. 17 men with symptoms of prostatitis for more than one year who had not responded to treatment courses of six weeks trimethoprim-sulfamethoxazole or trimethoprim alone received 500 mg ciprofloxacin twice daily per os for two weeks. Up to one year follow-up proved eradication of Escherichia coli in seven of ten and of other pathogens in two of five cases. In a second study, 16 patients with proven chronic bacterial prostatitis who had failed on pretreatment with co-trimoxazole, trimethoprim or norfloxacin, respectively, received 500 mg ciprofloxacin twice daily for four weeks. E. coli was the causative organism for all cases. After a median follow-up of 30 (21-36) months, ten out of 16 patients are clinically cured with permanent eradication of the causative organism. In two men a second treatment course with ciprofloxacin is considered successful. Two patients stopped treatment for central nervous system complaints.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2055654     DOI: 10.1007/bf01643690

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  10 in total

Review 1.  Treatment of genitourinary tract infections with fluoroquinolones: activity in vitro, pharmacokinetics, and clinical efficacy in urinary tract infections and prostatitis.

Authors:  J S Wolfson; D C Hooper
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

Review 2.  Ciprofloxacin as treatment for genitourinary tract infection.

Authors:  S J Childs; E J Goldstein
Journal:  J Urol       Date:  1989-01       Impact factor: 7.450

3.  Diffusion of ciprofloxacin into prostatic fluid.

Authors:  A Dalhoff; W Weidner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-06       Impact factor: 3.267

Review 4.  Use of quinolones in urinary tract infections and prostatitis.

Authors:  K G Naber
Journal:  Rev Infect Dis       Date:  1989 Jul-Aug

5.  Treatment of chronic bacterial prostatitis with ciprofloxacin. Results of a one-year follow-up study.

Authors:  W Weidner; H G Schiefer; A Dalhoff
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

6.  Diffusion of ciprofloxacin into prostatic fluid.

Authors:  A Dalhoff; W Weidner
Journal:  Eur J Clin Microbiol       Date:  1984-08       Impact factor: 3.267

7.  Refractory chronic bacterial prostatitis: a re-evaluation of ciprofloxacin treatment after a median followup of 30 months.

Authors:  W Weidner; H G Schiefer; E Brähler
Journal:  J Urol       Date:  1991-08       Impact factor: 7.450

8.  Ciprofloxacin (BAY 09867): clinical evaluation in urinary tract infections due to Pseudomonas aeruginosa.

Authors:  J M Guibert; D M Destree; J F Acar
Journal:  Chemioterapia       Date:  1987-06

Review 9.  Prostatitis: review of pharmacokinetics and therapy.

Authors:  E M Meares
Journal:  Rev Infect Dis       Date:  1982 Mar-Apr

10.  Concentration of ciprofloxacin in human prostatic tissue after oral administration.

Authors:  M Dan; J Golomb; A Gorea; Z Braf; S A Berger
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

  10 in total
  3 in total

Review 1.  The role of quinolones in the treatment of chronic bacterial prostatitis.

Authors:  K G Naber
Journal:  Infection       Date:  1991       Impact factor: 3.553

Review 2.  Ciprofloxacin. A review of its pharmacological profile and therapeutic use in the elderly.

Authors:  L R Wiseman; J A Balfour
Journal:  Drugs Aging       Date:  1994-02       Impact factor: 3.923

Review 3.  Chronic prostatitis: management strategies.

Authors:  Adam B Murphy; Amanda Macejko; Aisha Taylor; Robert B Nadler
Journal:  Drugs       Date:  2009       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.